Outsourced Pharma Capability Update Small Molecules

As the leading global CDMO for small molecules, Siegfried combines deep scientific expertise, integrated development and manufacturing, and a global network of 10 small molecules manufacturing sites across the US, Europe and China. Our network provides flexible capacity, technology transfer and dual-supply options to strengthen security of supply. With 150+ years of experience and 1,600+ development projects, we bring deep expertise in complex chemistry, high-potency APIs and controlled substances. From pre-clinical development through commercial supply, our integrated capabilities enable seamless scale-up, preserve process knowledge and support reliable supply throughout the product lifecycle. Originally presented at Outsourced Pharma Capabilities Update: Advanced Small Molecules on October 28, 2026.